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Transportation of blood samples is unavoidable for assessment of specific parameters
in blood of patients with rare anemias, blood doping testing, or for research purposes.
Despite the awareness that shipment may substantially alter multiple parameters, no
study of that extent has been performed to assess these changes and optimize
shipment conditions to reduce transportation-related artifacts. Here we investigate the
changes in multiple parameters in blood of healthy donors over 72 h of simulated
shipment conditions. Three different anticoagulants (K3EDTA, Sodium Heparin, and
citrate-based CPDA) for two temperatures (4◦C and room temperature) were tested
to define the optimal transportation conditions. Parameters measured cover common
cytology and biochemistry parameters (complete blood count, hematocrit, morphological
examination), red blood cell (RBC) volume, ion content and density, membrane properties
and stability (hemolysis, osmotic fragility, membrane heat stability, patch-clamp
investigations, and formation of micro vesicles), Ca2+ handling, RBC metabolism,
activity of numerous enzymes, and O2 transport capacity. Our findings indicate that
individual sets of parameters may require different shipment settings (anticoagulants,
temperature). Most of the parameters except for ion (Na+, K+, Ca2+) handling and,
possibly, reticulocytes counts, tend to favor transportation at 4◦C. Whereas plasma and
intraerythrocytic Ca2+ cannot be accurately measured in the presence of chelators such
as citrate and EDTA, the majority of Ca2+-dependent parameters are stabilized in CPDA
samples. Even in blood samples from healthy donors transported using an optimized
shipment protocol, the majority of parameters were stable within 24 h, a condition that
may not hold for the samples of patients with rare anemias. This implies for as short as
possible shipping using fast courier services to the closest expert laboratory at reach.
Mobile laboratories or the travel of the patients to the specialized laboratories may be
the only option for some groups of patients with highly unstable RBCs.
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INTRODUCTION
Guidelines to handle blood samples for analysis in clinical
laboratories have been established and are continuously
updated by the International Council for Standardization in
Hematology. However, these guidelines refer mostly to standard
operating procedures (SOPs) for particular types of analysis
and the instrumentation for assessment of the standard clinical
parameters. Whereas, the safety of shipment of blood samples
is regulated by the guidelines issued by the World Health
Organization (World Health Organization Division of Emerging
and Other Communicable Diseases Surveillance and Control,
1997), the quality of blood samples shipped is not referred to in
these documents.
The situation gets even more complicated when it comes
to basic research. Although most researches are aware of the
impact of transportation time and temperature on red blood
cell (RBC) stability and function (Minetti et al., 2013), there is
neither a guideline nor a common practice to follow. The best
way to avoid negative influences of storage and transportation
conditions is to perform the measurements immediately after
blood withdrawal. However, even in fresh blood the results may
be severely affected by the choice of anticoagulant. Detailed
examination of RBCs from patients with rare anaemias (Vives-
Corrons et al., 2014) requires the coordinated action of several
laboratories andmakes shipment to expertise centers compulsory
due to the low prevalence of these rare disorders.
In principle there should not be a huge difference between
transportation and storage, except that (i) for transportation it
is more difficult to maintain conditions like the temperature
constant or to control shear stress to which the samples may be
exposed and (ii) clinical practice and laboratory conditions at the
place of blood collection may not allow for complicated or time
consuming procedures, e.g., for blood component separation,
after blood withdrawal.
Putative lysis of white blood cells and platelets and the
associated enzyme release is of particular importance as are
known to have negative effects on the RBCs and are difficult
to control. Leucodepletion before shipment would improve the
quality of RBCs and reduce the transportation-related artifacts.
However, this is often not possible also due to a limited blood
sample size of anemic patients or children.
In the present study we have evaluated the impact of up
to 3 days of transportation of whole blood collected from
healthy donors into standard vacutainers supplemented with
the most widespread anticoagulants (K3EDTA, Sodium Heparin,
and citrate-based CPDA) at 4◦C or at room temperature
on a number of parameters measured with common and
specialized techniques used within the research consortium
CoMMiTMenT, Combined Molecular Microscopy for Therapy,
and Personalized Medication in Rare Anemia Treatments’.
Measurements were performed in parallel in four laboratories
in Barcelona, Homburg/Saar, Utrecht, and Zürich. Although the
present study was performed on blood of healthy volunteers,
we aimed for producing some guidelines for optimal shipment
conditions for whole blood samples for investigations of RBCs
from patients with rare and very rare anaemias to ensure
reproducibility of results obtained by different groups within the
consortium and beyond.
MATERIALS AND METHODS
Blood Withdrawal
In all laboratories participating in the present study the same
blood collection system (Vacutainer Blood Collection Set REF
367282, Becton, Dickinson and Co., Franklin Lakes, NJ, USA)
and the same batches of 9mL containers for K3EDTA (referred
to as EDTA), Sodiumheparin (referred to as heparin) and citrate
phosphate dextrose-adenine (referred to as CPDA), respectively,
(Vacuette, Becton, Dickinson and Co., Franklin Lakes, NJ,
USA) were used. For the sake of standardization, six tubes
of blood were collected from each donor (3 anticoagulants ×
2 transportation temperatures) at the nominal tube capacity
to ensure well-defined anticoagulant concentrations. However,
depending on the duration of the experiments to perform,
the time points of withdrawal for the different conditions
may have been adapted. In other words: the time schedule
of the experiments was given the priority at the cost that
blood withdrawal (of the same donor) was at different time
points. For all participating laboratories ethical statements of
the national authorities have been granted (permissions for
UMC Utrecht: approval number 07/125 Mini Donor Dienst, for
IDIBAPS Barcelona: approval number 2013/8436 of the Ethical
Committe for Clinical Investigations’, for Saarland University:
approval number 123/08 of Ärztekammer des Saarlandes and
for University of Zürich: the Canton’s ethics committee of
canton Zurich KEK ZH NR 2010-0237). Within this study we
investigated blood samples from 22 donors.
Transportation Conditions
Freshly drawn whole blood samples supplemented with heparin,
CPDA, or EDTA were stored at 4 ± 1◦C (in a refrigerator or
cold storage room) and at room temperature 22 ± 2◦C. To
simulate transportation, we introduced cycles of immobilization
with several rounds of shaking a day. Different shakers have
been used but we sticked to a protocol of a shaking frequency
of 120 per minute for a total of 3 h shaking within a 24 h period
divided into 3 intervals. The whole range of parameters listed in
Sections from Complete Blood Count (CBC) to Measurements
of Hemoglobin O2 Affinity, pO250 was measured in these blood
samples within the first hour of blood collection, at 24, 48, and
72 h after blood withdrawal. All statistical analysis, even in case
of single cell methods, were based on the donors.
Complete Blood Count (CBC)
Automatic cell analyzers, ADVIA 2120 (Hematology System,
Siemens Healthcare Diagnostics, Forchheim, Germany) and
Cell-Dyn Sapphire (Abbott Diagnostics Division, Santa Clara,
CA, USA) were used to measure hematological parameters:
red blood cell count (RBC), hemoglobin concentration (Hb),
RBC volume percentage (HCT), mean cell volume (MCV),
mean cell hemoglobin (MCH), mean corpuscular hemoglobin
concentration (MCHC), and absolute as well as percentage
number of reticulocytes in all samples.
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Morphology Examination
Peripheral blood smears were prepared on microscope slides
(Menzel-Gläser, Braunschweig, Germany) and stained with
a May–Grünwald-Giemsa protocol. The staining procedure
consisted of immersing the slides for 1.5min in May–Grünwald’s
eosin-methylene blue solution (Merck, Darmstadt, Germany)
and, after washing up the excess solution with water, staining
the slides for 20min with 10% Giemsa stain solution (Merck,
Darmstadt, Germany). Furthermore, slides were left to dry
for at least 30min (Vives Corrons et al., 2004). Slides were
visualized with an Olympus Vanox-T AH-2 microscope (Tokyo,
Japan), equipped with an Olympus DP73 digital camera, using
a 100× oil objective (Olympus SPlan 100PL). Digital images
were assessed using CellSens Entry software (V1.7, Olympus,
Tokyo, Japan).
Percoll Centrifugation of RBCs
For RBC separation on a Percoll (GE Healthcare, Little Chalfont,
Buckinghamshire, UK; density 1.13 g/mL) density gradient
0.5mL of blood sample were gently placed on top of the 90%
Percoll mixture [9:1:1.1 of percoll: 10× buffer C: 1× buffer
C containing (in mM): 140 NaCl, 4 KCl, 0.75 MgSO4, 10
glucose, 2 CaCl2, 0.015 ZnCl2, 0.2 Gly, 0.2 Glu, 0.2 Ala, 0.1
Arg, 0.6 Gln, 20 HEPES-Imidazole, pH 7.4 at 37◦C)]. This
buffer was designed taking into accounts recent findings on the
role of plasma-borne amino acids and Zn2+ ions in control
of Ca2+ uptake by RBCs (and thereby activity of Gardos
channels and RBC volume, Makhro et al., 2013, 2016) and
NO production by endothelial NO synthase in RBCs (Makhro
et al., 2010). Then samples were centrifuged at 45,000 g for
30min and the distribution of RBCs within the gradient was
recorded.
Blood Gases, pH-Value, and Plasma
Composition
A blood gas analyzer ABL 700 (Radiometer, Brønshøj, Denmark)
was used to measure pH, COHb, MetHb, electrolytes (K+,
Na+, Cl−) and lactate in blood samples. For the K+ and Na+
plasma content, measurements were corrected by the amount
of K+ and Na+ measured in aqueous solution containing
1.8mM CaCl in the respective anticoagulant tubes. Glucose
concentration was measured in blood drops by a Contour Blood
Glucose Monitoring System (Bayer AG, Zürich, Switzerland). All
measurements were done in triplicates.
Hemolysis and Determination of
Hemoglobin Content
To assess RBCs spontaneous hemolysis during the
transportation, blood samples were centrifuged at 3,000 g
for 5min. Then supernatant was removed and free hemoglobin
concentration was measured using the spectrophotometric kit
LCN 043 Hemoglobin Solution Transformation (Dr. Lange,
Hach Lange GMBH, Düsseldorf, Germany). Hemolysis was
assessed by the amount of released free hemoglobin to the total
hemoglobin available in the blood sample.
Osmotic Fragility Test (OFT) and Osmotic
Gradient Ektacytometry
RBC osmotic fragility test (OFT) was performed with the
classical multiple tube technique. This method measures the
susceptibility of “fresh” RBCs (immediate OFT) and after 24 h
of incubation at 37◦C (incubated OFT), to osmotic swelling and
lysis in increasingly hypotonic saline solutions (range: 8–0 g/L
NaCl). Optical density (OD) of the supernatants was measured
using a spectrophotometer at 540 nm for calculation of the 50%
hemolysis value.
Additionally, osmotic gradient ektacytometry of RBCs
was performed using a Laser-assisted Optical Rotational
Deformability Cell Analyzer (LoRRca MaxSis, RR Mechatronics,
Zwaag, The Netherlands; Osmoscan mode) according to the
manufacturer’s instructions. Sample volumes of whole blood
were standardized to hemoglobin concentrations of 8.0mmol/L
andmixed with an isotonic polyvinylpyrrolidone (PVP) solution.
RBCs were then subjected to an increasing gradient in osmolarity
(range: 80–550 mOsmol/L) under constant shear stress (30 Pa).
Thus, the deformability of RBCs [expressed as elongation index
(EI)] was measured as a function of continuously changing
osmotic conditions. The EI is defined as the ratio between
(A−B)/(A+B), where A and B are defined as the length and the
width of the RBC population under this changing osmolality at
constant shear stress. Results were analyzed with the supplied
Osmoscan software.
Membrane Heat Stability Test
The sensitivity of the RBC membrane to heat was tested at
three different incubation times (15, 30, and 60min) and at two
different temperatures (46 and 49◦C) in a cacodylate solution
(Vives-Corrons and Aguilar Bascompte, 2014). RBCs fixed in
glutaraldehyde were visualized as described for the morphology
analysis.
Red Blood Cell-Derived Vesicles
For ELISA experiments, whole blood was centrifuged for 10min
at 2,000 g and the obtained plasma was further centrifuged
for 10min at 10,000 g to remove residual cells and debris.
Plasma was then diluted and transferred to Nunc Maxicorp R©
flat-bottom 96 plates, which were coated overnight with
monoclonal mouse anti-human CD235a antibodies [HIR2 (also
GA-R2), IgG2bκ, eBioscience, San Diego, CA, USA]. Biotinylated
monoclonal mouse anti-human CD235a [HIR2 (also GA-
R2), IgG2bκ, eBioscience, San Diego, CA, USA] and isotype
controle IgG2bκ (eBMG2b, eBioscience, San Diego, CA, USA)
were used as secondary antibodies. Finally, streptavidin poly-
HRP (Sanquin) and Super Signal West Pico Chemiluminescent
Substrate (Thermo Scientific, Waltham, MA, USA) were used
as detection reagents and measured using a Biotek Syngery2
plate reader. For Western Blot analysis, vesicles from plasma
were first isolated using differential centrifugation, one time for
45min at 10,000 g followed by two times for 70min at 100,000
g, in a Beckman Coulter Optima L-90K. Samples were dissolved
in DTT containing sample buffer and equally loaded (10µg
protein) on 10% SDS-page gels. After migration, samples were
loaded to PVDF membranes and incubated with monoclonal
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mouse anti-human Band 3 (BIII-136, Sigma Aldrich, St. Louis,
MO, USA) and polyclonal rabbit anti-human CD235a (Thermo
Scientific, Waltham, MA, USA) antibodies.
Patch-Clamp Measurements
Patch-clamp measurements were performed with a Patchliner
(Nanion Technologies, Munich, Germany). The resistance of
chips was between 5 and 8 M with internal solution (in mM):
CsCl 50, CsF 60, NaCl 20, EGTA 20, HEPES 10, MgATP 5, pH =
7.2, and external solution (in mM): NaCl 140, KCl 4, MgCl21,
CaCl22, D-glucose 5, HEPES 10, pH = 7.3. Gigaseals were
considered successful if exceeding 1 G (although on most cells
they were above 5–10 G). Gigaseal formation was facilitated
by the use of a seal enhancing solution as recommended by the
manufacturer of the Patchliner containing (inmM): NaCl 80, KCl
3,MgCl210, CaCl235, HEPES (Na+ salt) 10, pH= 7.4.Whole-cell
configuration was achieved by negative pressure suction pulses of
between−45 and−150mbar and its formation was judged by the
appearance of sharp capacitive transients.
Calcium Imaging
Ca2+imaging was performed based on the Ca2+-fluorophor
Fluo-4 (Life technologies, Calsbad, CA, USA) using a protocol
of stimulation with lysoposphadidic acid (LPA, Sigma-Aldrich,
St-Louis, MO, USA) and a consecutive analysis as previously
described (Wang et al., 2013). Basal Ca2+-related fluorescence
was measured as described before (Wang et al., 2014).
Number of Active NMDA-Receptors
Per Cell
To avoid white blood cell contamination, blood samples were
filtered thought 1:1 α-cellulose and crystalline cellulose (Sigma-
Aldrich, St. Louis, MO, USA). Then RBC concentration was
adjusted to 20% HCT by buffer C and cells were incubated
with the NMDA receptor channel blocker [3H]MK-801 5µL/mL
of sample (stock solution of 5 × 10−7 mmol/mL, specific
activity of 20 Ci/mmol, PerkinElmer, Waltham, MA, USA,
#NET972001MC) for 1 h. Subsequently RBCs were washed in
buffer C supplemented with 0.1% BSA for three times (3,000
g, 5min) and the final volume of RBC mass was determined
as hematocrit. Next, one part of packed cells was mixed with
30 parts of lysis buffer (25mM NaH2PO4 and 1mM EDTA,
pH 7.0) and incubated on ice for 30min. RBC membranes
were precipitated (45,000 g, 30min at 4◦C) and the amount of
[3H]MK-801 molecules bound to NMDA receptors was assessed
using Packard 1600 TR liquid scintillation analyzer (PerkinElmer,
Waltham, MA, USA). The quantity of NMDA receptors per cell
was calculated as described elsewhere (Makhro et al., 2013).
Measurements of Metabolic Activity and
Glycolytic Enzymes’ Activity
For ATP and GSH measurements a 200µL blood sample
was mixed with 800µL 5% trichloroacetic acid and frozen
in liquid N2 until the GSH and ATP measurements were
performed. Defrosted samples were then centrifuged at 16,000 g
for 10min, pellet discarded and the concentration of reduced and
oxidized glutathione was detected in the supernatant as described
elsewhere (Tietze, 1969; Bogdanova et al., 2003). ATP content was
measured in the supernatant after pH adjustment by saturated
TRIS solution with an Adenosine 5′- triphosphate (ATP)
Bioluminescent Assay Kit for ATP quantitation (Sigma-Aldrich,
St. Louis, MO, USA). For measurements of enzymatic activity
RBCs were isolated by using an α-cellulose column and stabilized
in a β-mercapto-ethanol solution. Hexokinase (HK), glucose-6-
phosphate dehydrogenase (G6PD), phosphofructokinase (PFK),
and pyruvate kinase (PK) activities were measured according to
standardized operating procedures (Beutler et al., 1977).
Measurements of Hemoglobin O2 Affinity,
pO250
Hemoglobin affinity was measured using a Hemox analyzer (TCS
Scientific, New Hope, PA, USA). Fifteen microliters of blood
were suspended in 5mL of plasma-like buffer C in a Hemox
cuvette. After temperature adjustment oxygen was displaced by
N2 gas from∼150 to 1mmHg oxygen pressure for 5min. P50 was
automatically calculated from the resulting hemoglobin affinity
curve.
RESULTS
In order to assess the impact of ions and Ca2+ chelators in
standard anticoagulants’ mixtures on the plasma pH, free Ca2+ as
well as Na+ and K+ levels in plasma and RBCs, the aqueous non-
buffered solutions of 1.8mM CaCl2 were fed into the standard
CPDA-, heparin,- and EDTA-filled vacutainers. pH and Ca2+ of
the resulting anticoagulant-supplemented mixture was assessed
using sensors of ABL700 blood analyzer. As follows fromTable 1,
both CPDA and EDTA contributed to the significant acidification
of the solution and reduction in free Ca2+ ion availability to the
edge of detection limit or below. However, the pH-buffer capacity
of RBCs is sufficient to completely buffer the pH change induced
by EGTA (Figure 9, bottom, right, green square), but not the
one induced by CPDA (Figure 9, bottom, middle, green square).
Usage of heparin had no impact on the pH levels in the solution
and reduced free Ca2+ levels in it by 0.2mM.
Correction should be performed when plasma Na+ and
K+ content is assessed in any of the anti-coagulants. Usage
of EDTA introduces 17.43 ± 0.39mM K+ within the 10mL
vacutainer whereas using standard 10mL CPDA- as well as
heparin vacutainers results in the immediate supplementation
of 40.73 ± 0.22 or 0.43 ± 0.03mM Na+ to the blood plasma.
Furthermore, CPDA vacutainers contain extra liquid and a
dilution coefficient has to be applied to correct for it.
Complete Blood Count (CBC)
Due to well established procedures and instructions of device
manufacturers CBC was exclusively performed using EDTA,
because it is a widely accepted standard condition applied in
a number of previous transportation studies (e.g., Lombardi
et al., 2011; Ashenden et al., 2012). Figure 1 summarizes
the data on the changes in the RBC count, Hb, HCT,
MCV, MCH, MCHC, and reticulocyte counts (RC) in the
course of transportation. Measurements were performed in two
independent laboratories using two standard devices ADVIA
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TABLE 1 | pH-values and Ca2+-concentrations obtained for aqueous solution of 1.8mM CaCl2 filling the vacutainers.
Parameter Control (without anticoagulant) heparin CPDA EDTA
pH 6.950±0.008 6.936± 0.001 5.852± 0.0009*** 6.262 ± 0.010***
Ca2+ (mM) 1.83±0.02 1.6± 0.02*** 0.04± 0.006*** below detection limit
All measurements were performed in triplicates. Errors represent standard errors of mean (SEM). ***stands for p < 0.001 compared to control.
FIGURE 1 | Complete blood count (CBC). (A) CBC parameters for EDTA anti-coagulated RBCs over time at 4◦C (blue triangles) and at 22◦C (red circles).
Evaluated parameters are the red blood cell number (RBC) per µL blood, hemoglobin (Hb) in mmol/L, hematocrit (HCT) in %, mean cell volume (MCV) in fL, mean cell
hemoglobin (MCH) in fmol of Hb monomers and mean corpuscular hemoglobin concentration (MCHC) in mmol/L. For orientation the MCHC control value of
21.3mmol/L corresponds to 34.3 g/dL. All measurements were performed on samples from 7 donors. (B) Absolute as well as percentage number of reticulocytes
(RC) performed with two different cell analyzers as indicated. The number of donors measured with the ADVIA 2120 cell analyzer and the Cell-Dyn Sapphire analyzer
were 3 and 4, respectively. For the measurements with the ADVIA 2120 Cell analyzer the time course of the RC was fitted linearly for 4◦C and a one phase decay fit for
22◦C. The goodness of fit R2 is given in the diagrams. Error bars represent SEM. Plotted significances are relative to control conditions; n.s., not significant; *p < 0.05;
**p < 0.01; ***P < 0.001.
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2120 cell analyzer and Cell-dyn Sapphire. All RBC indices
were consistent (no significant difference) when assessed by
both analyzers (Figure 1A) except for the RC (Figure 1B). RBC
count and Hb did not change significantly within 72 h of
simulated transportation at either temperature tested, whereas
HCT, MCV, and MCHC were only stable at 4◦C (n = 6
donors for all parameters). Shipment at room temperature was
associated with RBC swelling (Figure 1A). Figure 1B provides
readouts for the RC obtained with ADVIA 2120 and Cell-
Dyn Sapphire analyzers. The measurements with the ADVIA
2120 cell analyzer indicated a clear decline over time, which
was more pronounced at 22◦C and could be explained by
reticulocyte maturation. In contrast, the Cell-Dyn Sapphire did
not detect significant changes in RC over time regardless of the
temperature. We were not the first to observe differences in
RC readouts between the blood analyzers. Such discrepancies
associated with the usage of different analysis equipment
were reported earlier (Lombardi et al., 2011; see also Section
Discussion).
The decline over time determined with the ADVIA 2120 cell
analyzer at 22◦C can be described by a one phase decay function
reaching a goodness of fit R2 of 0.84 and 0.89 for absolute and
relative RC, respectively. This allows to introduce a correction for
the transportation-induced decrease in RC. In contrast a linear fit
for the RC loss at 4◦C reaches a R2 of only 0.5.
Examination of RBC Morphology
Similar as for the CBC, morphology examination was exclusively
performed in EDTA. Representative micrographs of May–
Grünwald stained blood smears are provided in Figure 2A. For
22◦C after 24 h of transportation, already there is a significant
portion of echinocytes (yellow arrows in Figure 2A), which
increases over time. Better and more consistent results can
be achieved with transportation at 4◦C but even under these
conditions echinocytes are formed sporadically.
Cell Volume and Density Markers
Percoll Centrifugation of RBCs
RBC density distribution as presented in Figure 2B is reflecting
intracellular water/electrolyte balance. When swollen, the cells
have lower density and therefore appear higher on the density
gradient, while dehydrated cells band below the medium density
fraction within the Percoll gradient.
CPDA preserves cell density for both 22 and 4◦C
transportation. In EDTA and heparin a subpopulation of
swollen cells already appears after 24 h of storage at room
temperature. Moreover, the main population of RBCs moved
upward compared to control conditions, indicating over-
hydration. Abnormally swollen cells are more fragile when
mechanical force is applied and will hemolyse during high
speed centrifugation (see upper part of the EDTA tubes colored
in pink). Thus, if we use EDTA anticoagulation we may lose
the most fragile cells that are predisposed to swelling during
centrifugation and other mechanical manipulations (washing,
filtration etc.). Thereby, to anticoagulate RBC for the assessment
of density distribution one should use either heparin and ship the
samples at 4◦C or transport blood in CPDA at room temperature.
Plasma Ion Content
Plasma ion content measured within 30min after blood
collection varied substantially between the different
anticoagulants. One can see that loss of K+ from the cells
to plasma and Na+ accumulation from plasma into RBCs is
pronounced in EDTA and heparin whereas it was preserved in
CPDA (Figure 3A). The changes occurring in EDTA and heparin
affect the precision of microcapillary hematocrit measurements.
As can be seen from Table 2, hematocrit to hemoglobin ratio
for the blood samples collected in CPDA vacutainers is lower
than the one for heparin or EDTA-preserved blood. In general,
cationic composition is better preserved over time at 22◦C.
At 4◦C the ion gradients for K+ and Na+ seem to be severely
disturbed. Regarding Cl−, 4◦C transportation seems to provide
better conditions. Significant differences between the different
anticoagulants under control conditions are related to the K+
and Na+ content of the anticoagulant (see above).
Cell and Membrane Stability and
Deformability
Hemolysis
The rate of hemolysis progression in transported samples is
summarized in Figure 3B. The degree of hemolysis appears to be
independent of the temperature. Although there is no significant
change over time in any of the anticoagulants used, CPDA
anticoagulation shows the lowest variability.
Osmotic Fragility and Osmotic Gradient
Ektacytometry
Osmotic fragility and osmotic gradient deformability of RBC
during shipment were tested in two different laboratories by
two different methods: by a classical OFT and by osmotic
gradient ektacytometry (Osmoscan) by means of the LoRRca
(Figure 4). OFT gives the point where 50% of RBCs show lysis.
The Omin value obtained from the Osmoscan curve is considered
to represent the same point (Clark et al., 1983; Nemeth et al.,
2015). The maximum elongation (Elmax) indicates the point
where RBCs reach their optimal deformability of the RBCs under
shear stress. Ohyper, the osmolality at which the El reaches half
of its maximum value, is related to internal viscosity of RBCs
and thus to the cellular hydration status. In general 4◦C provides
better preservation of parameters for all anticoagulants tested,
with widely no changes over time compared to 22◦C. Elmax seems
stable for 48 h, declining thereafter, although this decline does not
reach significance.
Membrane Heat Stability Test
The heat stability test explores the sensitivity of RBCs membrane
to temperature. RBCs of healthy human subjects show no
changes when heated at 46◦C for 1 h. Transportation alters
membrane stability at 49◦C. This test is well-established in
EDTA-blood (Vives-Corrons and Aguilar Bascompte, 2014) and
was therefore exclusively performed in RBCs preserved in this
anticoagulant. Representative images of RBCs suspended in
gluteraldehyde at the different temperatures are provided in
Figure 5. Only transportation at 4◦C allowed stable readouts for
heat stability tests.
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FIGURE 2 | Morphological analysis and percoll centrifugation. (A) Representative images of RBCs from EDTA anti-coagulated blood. Smears stained by
May-Grünwald. Color of micrograph frames codes for the transportation temperature; blue, 4◦C; red, 22◦C; green, freshly drawn blood. The yellow arrows in the 4◦C
images and the 22◦C—24h image point to echinocytes. In the other 22◦C images the majority of the cells are echinocytes. (B) Percoll-centrifugation pattern of fresh
samples (30min) and after 24, 48, and 72 h. H, E, and C refer to the anti-coagulants heparin, EDTA, and CPDA, respectively. Blue letters denote transportation at 4◦C
and red letters at 22◦C.
Microvesicles
RBC-derived microvesicles are increasingly recognized as
mediators of signaling and regulation of processes in all blood
cell types as well as in vascular endothelium. CPDA has
proven to be the best anticoagulant preserving the microvesicles
during shipment at any temperature (Figure 6A). Additionally,
microvesicles were characterized after isolation for Glycophorin
A, Band 3, and Aktin. A representative Western blot and a
quantitative analysis is provided in Figures 6Ba,Bb, respectively.
These data confirm an increased in vitro vesiculation of RBCs
during transportation in heparin and EDTA.
Patch-Clamp Investigations
Although single cell analysis has numerous advantages (Minetti
et al., 2013), it is often laborious and time consuming and
poses restrictions in samples processing throughput. This
applies especially to the classical manual patch-clamp
technique and although we used a patch-clamp robot,
restrictions could only partly be relieved. We have thus
limited the parameters to monitor to the success rate in
formation of a gigaseal and the successful break-through
into the membrane (whole-cell configuration) (Figure 7A)
and avoided extensive time-consuming protocols for channel
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FIGURE 3 | Ionic plasma content and hemolysis. (A) Plasma K+-content, Na+-content, and Cl−-content as well as (B) hemolysis for heparin, CPDA, and EDTA
anti-coagulated blood over time at 4◦C (blue triangles) and at 22◦C (red circles). K+ and Na+ but not Cl− values were corrected for the particular ion content in the
anticoagulant. All measurements were performed on samples from at least 3 donors. Error bars represent SEM. Plotted significances are relative to control conditions;
n.s., not significant, *p < 0.05, **p < 0.01, ***P < 0.001. Significance of K+-content at control conditions: heparin vs. CPDA, p = 0.003; heparin vs. EDTA, p = 0.003;
CDPA vs. EDTA, p = 0.002. Significance of Na+-content at control conditions: heparin vs. CPDA, p < 0.0001; heparin vs. EDTA, p = 0.001; CDPA vs. EDTA,
p = 0.001. Significances of Cl−-content at control conditions are not given due to the lack of corrections for Cl−-content in the anticoagulants.
characterizations. Figure 7A reveals that out of the, in average,
74 ± 2% successful seals, only one third (25 ± 2%) reached a
measurable whole-cell configuration. There was no prevalence
for a particular transportation condition for these particular
parameters.
RBCs’ Ca2+-Handling
Live Cell Ca2+ Imaging
Assessment of the Ca2+-dependent fluorescence intensity of
fluo-4 in the format of live cell imaging allows to monitor
relative free Ca2+ levels in individual RBCs. As fluo-4 is a
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TABLE 2 | Haematrocrit (HCT) measured with microcapillaries and the
HTC—hemoglobin (Hb) ratio for the different anticoagulants used.
Parameter heparin CPDA EDTA
HCT (capillary) % 46.11 ± 1.7 39.28 ± 1.1* 43.42 ± 2.1
HCT/Hb 3.18 ± 0.082 3.20 ± 0.043 2.99 ± 0.033#
Errors represent SEM. *denotes p = 0.027 compared to heparin and # stands for p =
0.018 compared to CPDA.
non-ratiometric dye, it cannot be used for quantitative detection
of Ca2+ in RBCs (Kaestner et al., 2006) and the fluorescence
intensity is presented in arbitrary units (Figure 7B). Detection
of Ca2+ was performed in RBCs re-suspended in Ca2+-
containing extracellular media whereas of RBCs in EDTA or
citrate-containing CPDA anticoagulants were deprived of Ca2+
during transportation. For all anticoagulants used, shipment at
4◦C prevents membrane leakiness for Ca2+. RBCs in CPDA
retained their properties for 72 h at both temperatures tested
(Figure 7B).
Application of lysophosphatidic acid (LPA) is a popular
method of hormonal-like stimulation of RBCs using the
Ca2+-concentration as the read out (Yang et al., 2000;
Chung et al., 2007; Kaestner et al., 2012) and was therefore
included as a test assay (Figure 7B). The cell- and donor-
based variability in the LPA response (Wang et al., 2013) was
also reflected in the test for the transportation, not allowing
for a judgment toward the best transportation conditions.
Notably, the LPA-response was independent of the basal
Ca2+ content.
The Number of Active NMDA Receptors
Calcium uptake into RBCs is mediated by a number of
ion channels, NMDA receptors being one of them and the
number of [3H]MK-801 binding sites per cell is a quantitative
measure for the number of active NMDA receptors in RBCs
(Makhro et al., 2013). As follows from Figure 8A the number
of NMDA receptors may be reliably detected in shipped
RBCs within 72 h. Anticoagulants and temperature regime
are not important for the accuracy of [3H]MK-801 binding
assay.
RBCs Metabolism
Glutathione
The changes in GSH and GSSG in RBCs during the 72 h of
shipment simulation are presented in Figure 8B. Reduced
glutathione (GSH) drops by ∼30% within the first 24 h
of transport at both 4◦C and at room temperature. In
the following 24 h GSH levels remained stable in samples
‘shipped’ at 4◦C, but declined further in samples preserved
in heparin or EDTA, but not in CPDA, at room temperature
for 72 h. Oxidized glutathione was increasing approximately
three-fold on average only after 72 h of simulated shipment
of samples in EGTA stored at room temperature. Due
to the high inter-individual variation in response, these
changes, although substantial, did not reach statistical
significance.
ATP, Glucose, Lactate, and pH
Further indices of RBC metabolic activity included intracellular
ATP, plasma glucose consumption and plasma lactate, and
pH levels. For the ATP content inter-donor variation in
the intracellular ATP levels was particularly high confirming
earlier reports (Hess, 2014). Thus, it is difficult to issue
the “acceptable” range of ATP depletion, although it clearly
occurs during the transportation and appears to be the
lowest in CPDA-preserved samples (Figure 9). Transportation
at room temperature supported higher rates of glycolysis in
blood samples as follows from faster glucose uptake and
lactate release rates and more pronounced plasma acidification
independent of anticoagulants used. Plasma glucose content
was exceptionally high in blood plasma of samples preserved
in CPDA containing in addition to citrate buffer also dextrose
(D-glucose), monobasic Na-phosphate and adenine. Glucose
supplementation from anticoagulant increases plasma glucose
by ∼30mM preventing terminal glucose deprivation during
shipment. Slowing metabolic processes by cooling to 4◦C may
be beneficial for shipment preventing acidification and gradual
depletion of plasma glucose. Changes in the lactate content
are less severe at 4◦C and can, for this temperature for all
anticoagulants, be perfectly described with a linear function with
goodness of fit R2 values between 0.99 and 1. The pH-value is
better preserved at 4◦C than at 22◦C. Although at 4◦C the pH-
value also decreases over time, this decline can be very well-
described with a linear fit reaching a goodness of fit R2 between
0.97 and 0.99 for the different anticoagulants. The control value
in CPDA is significantly reduced compared to the other two
conditions due to the acidic nature of CPDA (compare Table 1).
Activity of Glycolytic Enzymes
In the context of rare anemias, glucose-6-phosphate
dehydrogenase (G6PD), hexokinase (HK), phosphofructokinase
(PFK), and pyruvate kinase (PK) are enzymes that can be affected.
It should be noted though that spectrophotometric analysis is of
limited sensitivity and fails to detect moderate to small changes
in G6PD activity (Peters et al., 2015). Measurements of these
enzymatic activities are summarized in Figure 10. Variability
in samples and measurements hampers a judgment of the
transportation conditions but general tendencies favor sample
transportation at 4◦C and may hint to an exclusion of EDTA as
an anti-coagulant.
Hemoglobin and O2-Binding Affinity
Methemoglobin and carbaminohemoglobin fractions and O2-
binding affinity were detected in transported blood samples.
Shipment of blood was associated with a minor increase in Met
Hb levels that was significant in samples preserved in CPDA
and EGTA and in transport for 36–72 h at room temperature
(Figure 11). In all samples Met Hb did not exceed 1.2%
remaining within physiological range. CO2 Hb levels were not
affected by transportation. In contrast, O2 affinity of Hb increased
substantially after 48 and 72 h of shipment at room temperature,
but not in blood samples transported at 4◦C. Thus, for Hb O2
affinity detection it is crucial to ship the samples at 4◦C.
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FIGURE 4 | Deformability Test. The classical osmotic fragility test provides the 50% hemolysis point (H50). The ektacytometry deformability curves provide three
characteristic parameters: the osmolality at which the minimum elongation index (EI) is reached (Omin), the maximum value of the EI (EImax), and the osmolality at
which the EI reaches half of its maximum value (Ohyper). All parameters are provided for heparin, CPDA, and EDTA anti-coagulated blood over time at 4
◦C (blue
triangles) and at 22◦C (red circles). All measurements were performed on samples from at least 3 donors. Error bars represent SEM. Plotted significances are relative
to control conditions; n.s., not significant; *p < 0.05; **p < 0.01; ***P < 0.001.
DISCUSSION
Practical Outcomes of the Study and
Optimal Shipment Conditions
If we regard a transportation condition as best, when under
one condition (anti-coagulant and temperature) all time points
show maximal consistency and minimal differences with control
values, we have to admit that we face a complex situation lacking
an universal optimal shipment condition for all parameters we
have measured. For example cation gradients are best preserved
at 22◦C (Figure 3A), whereas heat stability tests are only reliable
when blood is stored at 4◦C (Figure 5). Heparin anticoagulated
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FIGURE 5 | Heat stability test in EDTA-blood. Representative images of EDTA anti-coagulated RBCs in gluteraldehyde. Transportation conditions (temperature
and time) are given left of the image rows. Additionally, the frames of the micrographs code for the transportation temperature; blue, 4◦C; red, 22◦C, green, freshly
drawn blood. Above the image-columns the conditions of the acute treatment (temperature and interval) are provided. The predominant shape of the RBCs as a result
of the treatment is indicated in the micrographs.
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FIGURE 6 | Investigations of microvesicles. (A) Amount of RBCs-derived microvesicles determined by ELISA for heparin, CPDA, and EDTA anticoagulated blood
over time at 4◦C (blue triangles) and at 22◦C (red circles). (Ba) Characterization of the microvesicles by Western blots under the transportation conditions given above
the plots at 4◦C for the proteins noted right of the blots. (Bb) Quantification of Western blots as exemplified in (Ba) for the RBC proteins Band 3 (black), Glycophorin A
(mangenta), and beta-Actin (cyan) in heparin, CPDA, and EDTA anticoagulated blood. All measurements were performed on samples from at least 3 donors. Error
bars represent SEM. Plotted significances in (Bb) are relative to time point t = 0 h.; n.s., not significant, *p < 0.05; **p < 0.01; ***P < 0.001.
blood is best for methemoglobin measurements (Figure 11),
CPDA anticoagulated blood—for microvesicles (Figure 6), and
EDTA anticoagulated blood—for pO250 (Figure 11), just to
name a few examples. The causes for such a variety draw the
attention to the two concepts for ex vivo cell preservation: (i)
instant conservation of the cell at the time of withdrawal and (ii)
maintenance of RBCs living conditions to keep the surrounding
undisturbed imitating in vivo parameters.
Most of the transport-induced alterations develop over time
(Figures 1–11) but some are the result of acute effects as evident
for ion concentrations and pH (Figures 3, 9 and Table 1). Thus,
concept (i) can be illustrated by the instant alterations in plasma
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FIGURE 7 | Singe cell investigations. (A) Patch-clamp experiments (gigaseal formation and successful whole-cell configurations) and (B) determination of the basal
relative Ca2+content and stimulation of RBCs with lysophosphatidic acid (LPA) and fluorescence of the Ca2+fluorophor normalized to the situation before stimulation
(F/Fo) as a read-out for heparin, CPDA, and EDTA anticoagulated blood over time at 4◦C (blue triangles) and at 22◦C (red circles). All measurements were performed
on samples from 3 donors. Error bars represent SEM. Plotted significances are relative to control conditions; n.s., not significant; *p < 0.05; **p < 0.01.
ion content (Figure 3) and HCT/Hb levels (Table 2) reflecting
the changes in RBCs volume in CPDA and EDTA anticoagulants.
Both concepts (i) and (ii) could possibly be relevant for the
transportation-induced alterations in reticulocyte count for the
blood samples in EDTA (Figure 1B, ADVIA 2120), at 4 and
22◦C for concepts (i) and (ii), respectively. In this particular
case transportation at 4◦C provides less changes compared
to control conditions, whereas transport at 22◦C depicts an
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FIGURE 8 | NMDA receptors and Glutathione. (A) NMDA-receptor binding and (B) Glutathione (GSH) content as well as relative oxidized gluthatione (GSSG) for
heparin, CPDA, and EDTA anticoagulated blood over time at 4◦C (blue triangles) and at 22◦C (red circles). All measurements were performed on samples from at least
3 donors. Error bars represent SEM. Plotted significances are relative to control conditions; n.s., not significant; *p < 0.05; **p < 0.01.
exponential decay over time. Most of the problems appear
because both transportation conditions have shortcomings and
are often not taken into account. Investigations similar to our
study, although limited to the basic parameters of the CBC, have
been performed in the context of an Athlete’s Biological Passport
(ABP) model for doping control of elite athletes (Lombardi
et al., 2011; Ashenden et al., 2012) and are in good agreement
with our results (Figure 1). This observation deserves further
attention and raises a question on the qualities of measurements
of parameters contributing to the ABP. Cases similar to the
ongoing doping accusation against the speed skater Claudia
Pechstein (Zylka-Menhom and Siegmund-Schultze, 2010) reveal
how crucial precise RC assessment may be. The obtained data
summarized in Table 3 indicate that no single optimal shipment
condition can be suggested for all parameters we have monitored.
The optimal conditions are marked with X. These conditions
provide minimum changes in the selected parameters. This
does not mean, however, that changes in them do not occur
or are below detection limits, but rather that the changes
are minimized. The conditions indicated with (X) represent a
limited reliability and parameters containing only this status,
like the heat stability test or the glutathione measurement may
only be performed in fresh blood samples. Measurements of
selected parameters in cells shipped under conditions marked
with X* give values that change with time of transportation
following a certain pattern that can be described with a correcting
equation (e.g., lactate or pH-value at 4◦C in Figure 9) or are
modulated by an “offset” caused by the anticoagulant (e.g.,
Cl− for heparin and EDTA in Figure 3A or glucose for CDPA
in Figure 9). These parameters can in principle be corrected
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FIGURE 9 | RBCs’ metabolism. ATP content, glucose, lactate levels and pH-value for heparin, CPDA, and EDTA anticoagulated blood over time at 4◦C (blue
triangles) and at 22◦C (red circles). The time course of increase of lactate in RBCs in the different anticoagulants was fitted linearly for 4◦C and the goodness of fit R2
is given in the diagrams. The time course of the pH-value was fitted linearly for 4◦C and the goodness of fit R2 is given in the diagrams. All measurements were
performed on samples from at least 3 donors. Error bars represent SEM. Plotted significances are relative to control conditions; n.s., not significant; *p < 0.05;
**p < 0.01; ***P < 0.001. Significances of the glucose content at control conditions: heparin vs. CPDA, p < 0.0001; heparin vs. EDTA, p = 0.82; EDTA vs.
CPDA, p < 0.0001.
based on reference measurements undertaken at the particular
transportation conditions.
Insights into the Mechanisms of the
Observed Effects
The obtained findings suggest the existence of several clusters
of parameters that are regulated by “master regulators” that
may include intracellular Ca2+ and metabolic activity. In order
to relate the results for the parameters obtained we performed
cross correlation analysis trying to decipher interdependencies
between different measured parameters (Figure 12). It is
worthwhile to underline that these correlations are made across
laboratories and on blood samples from different donors.
Figure 12A presents more less obvious relations that could
be regarded as a quality control. Figure 12Aa shows the inverse
correlation between RBC volume and the plasma Cl−-content.
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FIGURE 10 | Enzymatic activity. Glucose-6-phosphate dehydrogenase (G6PD) activity, hexokinase (HK) activity, phosphofructokinase (PFK) activity, and pyruvate
kinase (PK) activity for heparin, CPDA, and EDTA anticoagulated blood over time at 4◦C (blue triangles) and at 22◦C (red circles). All measurements were performed
on samples from at least 3 donors. Error bars represent SEM. Plotted significances are relative to control conditions; n.s., not significant; *p < 0.05; **p < 0.01.
This reflects the role of Cl− in cell volume regulation as it
is known from previous publications (Rust et al., 2007). The
classical OFT parameter H50 correlates very well with the Omin
parameter from ektacytometry measurements (Clark et al., 1983;
Nemeth et al., 2015) as outlined in Figure 12Ab. Furthermore,
Figure 12Ac depicts the saturating relation between glucose
availability and cellular ATP content, in line with anaerobic
glycolysis being the only route for energy production in
RBCs.
Maintenance of transmembrane ion gradients implies that
Na+, K+,- and Ca2+-ATPases remain active. As follows from our
findings two factors are critically affecting the activity of the ion
pumps, the temperature and the fuel availability. Breakdown of
the Na+/K+ gradient becomes apparent as an inverse change
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FIGURE 11 | Hemoglobin and O2-binding affinity. Methemoglobin (Met Hb) fraction, carbaminohemoglobin (CO2Hb) fraction, and the 50% saturation value of the
hemoglobin for the partial pressure of O2 (pO250) for heparin, CPDA, and EDTA anticoagulated blood over time at 4
◦C (blue triangles) and at 22◦C (red circles). All
measurements were performed on samples from at least 3 donors. Error bars represent SEM. Plotted significances are relative to control conditions; n.s., not
significant; *p < 0.05; **p < 0.01; ***P < 0.001. Significances of the pH value at control conditions: heparin vs. CPDA, p = 0.0015; heparin vs. EDTA, p = 0.2; EDTA
vs. CPDA, p = 0.002.
in plasma Na+ and K+ levels revealing uptake of Na+ and
loss of K+ from RBCs (Figure 12B). These changes get more
prominent with time in cells preserved in heparin or EDTA (but
not CPDA) shipped at 4◦C. The time-course of the changes in
plasma ion content does not follow kinetics of ATP changes in
RBCs (Figures 3, 9). Thus, cooling most likely dominates the
loss of Na+/K+ and Ca2+ gradients in transported RBCs. Low
temperatures suppress the activity of ion transporters. With a
decrease in temperature by 10◦C (Q10), the Na+/K+-ATPase is
suppressed approximately three-fold (Canestrari et al., 1994) and
the Q10 of the Ca2+-pump is even 30-fold (Sarkadi et al., 1977).
This decrease in pump activity is associated with dissociation
of the Na+/K+ and Ca2+ gradients and re-distribution of Na+
and K+ between RBCs and plasma. However, ATP depletion
in RBCs preserved with heparin and EDTA most likely also
contributes to the dissipation of the ion gradients at later time
points. Although the onset and effects of cationic transmembrane
gradients breakdown are largely known (for review see Flatt et al.,
2014), detailed mechanisms still need further elucidation.
Comparing our control Cl− plasma concentration
with published plasma concentrations (Wissenschaftliche
Tabellen, 1979), we get the best agreement for our heparin
controls, although it is unclear if these published data
suffer from fast changes after withdrawal or if these
values reflect the in vivo situation and our measurements
in CPDA reveal a rapid decrease in the Cl− plasma
content.
The importance of Ca2+as a regulator of various RBCs
processes (Bogdanova et al., 2013) is highlighted by the panels
of Figures 12D. Alteration in the intracellular Ca2+ is initiated
as blood is collected into the vacutainer with the selected
anticoagulant. As indicated in Table 1, CPDA and EDTA
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FIGURE 12 | Correlations. Selected significant correlations of measured parameters presented in Figures 1–10. The diagrams include all available conditions
measured (all time points and all anticoagulants). In all diagrams r gives the Pearson-coefficient, R2 the goodness of fit, and p the significance value. (Aa) Correlation
between mean cellular volume (MCV) and plasma Cl−-content. (Ab) Correlation between the 50% hemolysis point (H50) of classical osmotic fragility tests and the
osmolality with the smallest deformability index (Omin) from an ectacytometer. (Ac) Relation between plasma glucose and cellular ATP content. (B) Correlation
between plasma K+-content and plasma Na+-content. (Ca) Correlation between plasma Na+-content and ATP. (Cb) Correlation between Ca2+-content and ATP.
(D) Correlation between Ca2+and the following parameters: Plasma Na+-content (Da), PFK-activity (Db), GSH (Dc), H50 (Dd), and microvesicles (De). (E)
Correlation between pH-value and oxygen binding affinity (pO250).
decrease the Ca2+-concentration lowering transmembrane
Ca2+-gradients by several magnitudes. Although transport
in Ca2+-free plasma should protect CPDA- and EDTA-
anticoagulated RBCs from Ca2+ overload and the associated
consequences (Bogdanova et al., 2013), placing the cells in a Ca2+
-containing media is necessary for certain measurements. RBCs
quickly replenish intracellular Ca2+, even when transported in
CPDA and EDTA but this often results in acute transient Ca2+
overload as the Ca2+ pump remains inactivated during transport
in a Ca2+-free environment.
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TABLE 3 | Summary of advisable transport conditions for the assessment
of particular parameters.
Parameter heparin CPDA EDTA
22◦C 4◦C 22◦C 4◦C 22◦C 4◦C
RBC-count n.d. n.d. n.d. n.d. X X
Hb n.d. n.d. n.d. n.d. X X
Hct n.d. n.d. n.d. n.d. X
MCV n.d. n.d. n.d. n.d. X
MCH n.d. n.d. n.d. n.d. X X
MCHC n.d. n.d. n.d. n.d. X
Reticulocyte count special (see text)
May-Grünwald stain n.d. n.d. n.d. n.d. X
CELL VOLUME AND DENSITY
Percoll density gradient X X X X
Plasma K+ X* X* X* X
Plasma Na+ X (X)
Plasma Cl− X X* X* X*
CELL AND MEMBRANE STABILITY AND DEFORMABILITY
Hemolysis X X
Osmotic fragility X X X
Ectacytometry X X X
Heat stability test n.d. n.d. n.d. n.d. (X)
Patch-clamp X X X X X
Microvesicles X X
HEMOGLOBIN FORMS AND O2 AFFINITY
MetHb (X) (X) X
CO2-Hb X X X X X X
pO250 X X X
Ca2+ Handling
Ca2+ imaging X X X X
NMDA receptor activity X X X X X X
RBC METABOLISM
Plasma glucose X* X* X*
ATP X X
Lactate X* X* X*
pH X* X* X*
G6PD X X X X
HK X X X X X X
PFK X X X X
PK X X X X X X
GSH (X) (X) (X) (X)
GSSG X X X X
n.d., not determined; X optimal condition; X* condition qualifies for determined
correction; (X) limited reliability.
The correlation between Ca2+and Na+ accumulation in RBCs
(Figure 12Da) most probably mostly reflects ATP deprivation
and its consequences on ion pumps as discussed above.
PFK is known to get dissociated from filamentous actin within
the cytoskeleton upon binding of Ca2+-calmodulin complex
(Zancan and Sola-Penna, 2005), the reaction that is inactivating
the enzyme (Real-Hohn et al., 2010). Of note, measurements of
the PFK activity are performed in RBC lysates in the absence
of Ca2+ (EGTA-containing buffers, Beutler et al., 1977). Thus,
inverse correlation may possibly reflect secondary effects of high
Ca2+ permeability. Suppression of PFK activity is observed in
RBCs preserved in both Ca2+ chelator EDTA and in those for
which heparin was used as an anticoagulant but not in CPDA
(Figure 10).
Figure 7B shows that regardless of the anticoagulant
used, the relative Ca2+ content immediately after blood
withdrawal is approximately the same. Therefore, we find
Ca2+-dependent correlations of the parameters depicted in
Figure 12D irrespective of the anticoagulant used.
Ca2+-dependence of GSH levels is an unexpected finding.
Although GSH was measured in blood samples without Ca2+
supplementation an inverse dependence was observed between
Ca2+ and GSH (Figure 12Dc). Since several steps of glutathione
biosynthesis are ATP dependent, the inverse correlation between
Ca2+and GSH is indirectly reflecting the ATP level in RBCs.
This is supported by a direct and significant correlation between
GSH and ATP (correlation not shown, r = 0.65, R2 = 0.42,
p = 0.0014).
Furthermore, the much higher rate of lactate production
correlated with the higher acidification rate and plasma
acidification at 22◦C compared to 4◦C shows that RBCs
metabolic processes are strictly temperature-dependent
(Figure 9). Over time, together with the buildup of lactate,
plasma pH, decreases and this, in addition to progressive glucose
depletion, suppresses glycolysis and contributes to the reduction
of ATP levels. Decreasing the temperature to 4◦C causes
suppression of both ATP production and ATP consumption as
ATPases and kinases are temperature-dependent (see above).
A correlation between pH-value and pO250 as presented in
Figure 12E cannot reflect the Bohr effect and is the opposite to
what one could expect from the link between pH and the amount
of 2,3-diphosphoglicerate produced in the course of glycolysis. It
awaits a molecular explanation in the future.
The correlation betweenH50 andCa2+ (Figure 12Dd) depicts
just one representative parameter out of the deformability
measurements presented in Figure 5. We believe these
parameters are related to the well described Ca2+ induced
increase in RBCs fragility (Cueff et al., 2010) including the
remodeling of RBCs cytoskeleton (Murakami et al., 1981) and
induction of tyrosine phosphorylation of band 3 (Minetti et al.,
1996, 2004) as well as an alteration of the lipid asymmetry of
plasma membrane (Wesseling et al., 2016). In line with this it
is known that Ca2+induces vesiculation of RBCs membrane
(e.g., Nguyen et al., 2011, 2016) by the activation of scramblase
and inhibition of flippase (Alaarg et al., 2013). Therefore, it is
not surprising that microvesicle abundance correlates with the
Ca2+-concentration (Figure 12De). Vesiculation increases over
time and this process is speeded up by room temperature but the
composition of vesicles differs for blood samples preserved with
different anticoagulants (Figure 6Ba). Ca2+ chelation protects
from intensive band 3 loss during vesiculation.
Measurements of the glycolytic enzymes’ activity are done in
the presence of saturating concentrations of substrates and co-
factors as well as at optimal pH. This explains the stability of
the enzymes’ activity values despite the changes occurring in the
intact cells and plasma. The only relevant factors in this case are
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proteolysis and irreversible oxidation. Both are clearly limited or
not occurring at any of the transport conditions chosen.
CONCLUSIONS
There is not one perfect transportation condition and therefore
anti-coagulants, temperature, and timing should be tested in
advance for every particular type of measurement. Nevertheless,
there is a general tendency that favors 4◦C shipping except for
cation gradients (Figure 3) and possibly for reticulocyte counts
(Figure 1B). Considering the importance and interdependencies
of Ca2+ with other RBCs parameters (Figure 12D) the
data presented here, suggest CPDA to be the best suitable
anticoagulant for most of the parameters tested. The reported
changes over time ask for as short as possible shipping times
and the use of healthy control samples to serve as shipping
controls.
Nevertheless, it can’t be ensured that blood samples from
patients and healthy donors would behave the same what
presents a limitation of this study and an enduring uncertainty.
However, the changes occurring in blood of patients with
rare diseases during shipment may be used as markers
that point to the possible causes of the disease (such as
alterations in metabolism, membrane leakiness for cations,
shipment-induced excessive hemolysis). In order to use these
abnormal shipment-induced RBC alterations as markers, blood
samples of healthy subjects should be shipped together with
the samples of patients. Special attention in the context of
diseased RBCs needs the hemolysis (Figure 3B) that might be
weighted higher than the other parameters, because this lysis
might preferably affect a particular (diseased) subpopulation of
the cells. Mobile laboratories or the travel of the patients to the
specialized laboratories could solve the transportation challenge
whenever absolutely required.
AUTHOR CONTRIBUTIONS
LK, JV, RV, AB, MM, and HE planned the study design; AM, RH,
LV, MD, EL, PP, JW, and AB performed experiments; AM, RH,
LV, MM, EL, PP, JW, AB, RV, and LK analyzed the data; LK wrote
the paper; AM, RH, MM, PP, HE, AB, RV, JV, and LK edited the
manuscript.
ACKNOWLEDGMENTS
The research leading to these results has received funding
from the European Seventh Framework Program under grant
agreement number 602121 (CoMMiTMenT).
REFERENCES
Alaarg, A., Schiffelers, R. M., van Solinge, W. W., and van Wijk, R. (2013). Red
blood cell vesiculation in hereditary hemolytic anemia. Front. Physiol. 4:365.
doi: 10.3389/fphys.2013.00365
Ashenden, M., Clarke, A., Sharpe, K., D’Onofrio, G., Plowman, J., and Gore, C. J.
(2012). Stability of athlete passport parameters during extended storage. Int. J.
Lab. Hematol. 35, 183–192. doi: 10.1111/ijlh.12014
Beutler, E., Blume, K. G., and Kaplan, J. C. (1977). International committee for
standardization in haematology: recommended methods for red cell enzyme
analysis. Br. J. Haematol. 35, 331–340.
Bogdanova, A., Makhro, A., Wang, J., Lipp, P., and Kaestner, L. (2013). Calcium
in red blood cells-a perilous balance. Int. J. Mol. Sci. 14, 9848–9872. doi:
10.3390/ijms14059848
Bogdanova, A. Y., Ogunshola, O. O., Bauer, C., and Gassmann, M. (2003). Pivotal
role of reduced glutathione in oxygen-induced regulation of the Na(+)/K(+)
pump in mouse erythrocyte membranes. J. Membr. Biol. 195, 33–42. doi:
10.1007/s00232-003-2042-8
Canestrari, F., Galli, F., Boschi, S., Albertini, M. C., Gheller, G., De Crescentini,
S., et al. (1994). Erythrocyte Na+,K(+)-ATPase properties and adenylate energy
charge in normotensives and in essential hypertensives. Clin. Chim. Acta 224,
167–179.
Chung, S.-M., Bae, O.-N., Lim, K.-M., Noh, J.-Y., Lee, M.-Y., Jung, Y.-S.,
et al. (2007). Lysophosphatidic acid induces thrombogenic activity through
phosphatidylserine exposure and procoagulant microvesicle generation in
human erythrocytes. Arterioscler. Thromb. Vasc. Biol. 27, 414–421. doi:
10.1161/01.ATV.0000252898.48084.6a
Clark, M. R., Mohandas, N., and Shohet, S. B. (1983). Osmotic gradient
ektacytometry: comprehensive characterization of red cell volume and surface
maintenance. Blood 61, 899–910.
Cueff, A., Seear, R., Dyrda, A., Bouyer, G., Egée, S., Esposito, A., et al. (2010). Effects
of elevated intracellular calcium on the osmotic fragility of human red blood
cells. Cell Calcium 47, 29–36. doi: 10.1016/j.ceca.2009.11.002
Flatt, J. F., Bawazir, W. M., and Bruce, L. J. (2014). The involvement of cation
leaks in the storage lesion of red blood cells. Front. Physiol. 5:214. doi:
10.3389/fphys.2014.00214
Hess, J. R. (2014). Measures of stored red blood cell quality. Vox Sang. 107, 1–9.
doi: 10.1111/vox.12130
Kaestner, L., Steffen, P., Nguyen, D. B., Wang, J., Wagner-Britz, L., Jung,
A., et al. (2012). Lysophosphatidic acid induced red blood cell aggregation
in vitro. Bioelectrochemistry 87, 89–95. doi: 10.1016/j.bioelechem.2011.
08.004
Kaestner, L., Tabellion, W., Weiss, E., Bernhardt, I., and Lipp, P. (2006). Calcium
imaging of individual erythrocytes: Problems and approaches. Cell Calcium 39,
13–19. doi: 10.1016/j.ceca.2005.09.004
Lombardi, G., Lanteri, P., Colombini, A., Lippi, G., and Banfi, G. (2011). Stability of
haematological parameters and its relevance on the athlete’s biological passport
model. Sports Med. 41, 1033–1042. doi: 10.2165/11591460-000000000-00000
Makhro, A., Haider, T., Wang, J., Bogdanov, N., Steffen, P., Wagner, C., et al.
(2016). Comparing the impact of an acute exercise bout on plasma amino acid
composition, intraerythrocytic Ca2+ handling, and red cell function in athletes
and untrained subjects. Cell Calcium. doi: 10.1016/j.ceca.2016.05.005. [Epub
ahead of print].
Makhro, A., Hanggi, P., Goede, J., Wang, J., Bruggemann, A., Gassmann, M.,
et al. (2013). N-methyl D-aspartate (NMDA) receptors in human erythroid
precursor cells and in circulating red blood cells contribute to the intracellular
calcium regulation. Am. J. Physiol. Cell Physiol. 305, C1123–C1138. doi:
10.1152/ajpcell.00031.2013
Makhro, A., Wang, J., Vogel, J., Boldyrev, A. A., Gassmann, M., Kaestner,
L., et al. (2010). Functional NMDA receptors in mammalian erythrocytes.
Am. J. Physiol. Cell Physiol. 298, C1315–C1325. doi: 10.1152/ajpcell.
00407.2009
Minetti, G., Ciana, A., and Balduini, C. (2004). Differential sorting of
tyrosine kinases and phosphotyrosine phosphatases acting on band 3
during vesiculation of human erythrocytes. Biochem. J. 337, 489–497. doi:
10.1042/bj20031401
Minetti, G., Egée, S., Mörsdorf, D., Steffen, P., Makhro, A., Achilli, C., et al.
(2013). Red cell investigations: art and artefacts. Blood Rev. 27, 91–101. doi:
10.1016/j.blre.2013.02.002
Minetti, G., Piccinini, G., Balduini, C., Seppi, C., and Brovelli, A. (1996).
Tyrosine phosphorylation of band 3 protein in Ca2+/A23187-treated human
erythrocytes. Biochem. J. 320, 445–450. doi: 10.1042/bj3200445
Frontiers in Physiology | www.frontiersin.org 20 July 2016 | Volume 7 | Article 288
Makhro et al. Red Cell Transportation
Murakami, T., Hatanaka, M., and Murachi, T. (1981). The cytosol of human
erythrocytes contains a highly Ca2+-sensitive thiol protease (calpain I) and its
specific inhibitor protein (calpastatin). J. Biochem. 90, 1809–1816.
Nemeth, N., Kiss, F., and Miszti-Blasius, K. (2015). Interpretation of
osmotic gradient ektacytometry (osmoscan) data: a comparative study
for methodological standards. Scand. J. Clin. Lab. Invest. 75, 213–222. doi:
10.3109/00365513.2014.993695
Nguyen, D. B., Thuy Ly, T. B.,Wesseling, M. C., Hittinger, M., Torge, A., Devitt, A.,
et al. (2016). Characterization of microvesicles released from human red blood
cells. Cell. Physiol. Biochem. 38, 1085–1099. doi: 10.1159/000443059
Nguyen, D. B., Wagner-Britz, L., Maia, S., Steffen, P., Wagner, C., Kaestner, L.,
et al. (2011). Regulation of phosphatidylserine exposure in red blood cells. Cell.
Physiol. Biochem. 28, 847–856. doi: 10.1159/000335798
Peters, A. L., van Bruggen, R., de Korte, D., Van Noorden, C. J. F., and Vlaar, A. P. J.
(2015). Glucose-6-phosphate dehydrogenase activity decreases during storage
of leukoreduced red blood cells.Transfusion 56, 427–432. doi: 10.1111/trf.13378
Real-Hohn, A., Zancan, P., Da Silva, D., Martins, E. R., Salgado, L. T.,
Mermelstein, C. S., et al. (2010). Filamentous actin and its associated binding
proteins are the stimulatory site for 6-phosphofructo-1-kinase association
within the membrane of human erythrocytes. Biochemie 92, 538–544. doi:
10.1016/j.biochi.2010.01.023
Rust, M. B., Alper, S. L., Rudhard, Y., Shmukler, B. E., Vicente, R., Brugnara, C.,
et al. (2007). Disruption of erythroid K-Cl cotransporters alters erythrocyte
volume and partially rescues erythrocyte dehydration in SAD mice. J. Clin.
Invest. 117, 1708–1717. doi: 10.1172/JCI30630
Sarkadi, B., Szász, I., Gerlóczy, A., and Gárdos, G. (1977). Transport parameters
and stoichiometry of active calcium-ion extrusion in intact human red-cells.
Biochim Biophys. Acta 464, 93–107. doi: 10.1016/0005-2736(77)90373-X
Tietze, F. (1969). Enzymic method for quantitative determination of nanogram
amounts of total and oxidized glutathione: applications to mammalian
blood and other tissues. Anal. Biochem. 27, 502–522. doi: 10.1016/0003-
2697(69)90064-5
Vives-Corrons, J.-L., and Aguilar Bascompte, J. L. (2014). “Métodos diagnósticos
de las membranopatías eritrocitarias,” in Manual de Técnicas de Laboratory en
Hematology, 4th Edn., eds J. L. Vives Corrons and J. L. Aguilar Bascompte
(Barcelona: Elsevier Health Sciences Spain), 536–586.
Vives Corrons, J.-L., Albarède, S., Flandrin, G., Heller, S., Horvath, K., Houwen, B.,
et al. (2004). Guidelines for blood smear preparation and staining procedure
for setting up an external quality assessment scheme for blood smear
interpretation. Part I: Control material. Clin. Chem. Lab. Med. 42, 922–926. doi:
10.1515/CCLM.2004.149
Vives-Corrons, J.-L., Manú Pereira, M. M., Pilar Nicolás, C. R.-C., Gulbis,
B., Angastiniotis, A. E. M., Aguilar Martínez, P., et al. (2014). ENERCA
Recommendations for Centres of Expertise in Rare Anaemias A White Book.
Madrid: Prodrug Multimedia SL.
Wang, J., van Bentum, K., Sester, U., and Kaestner, L. (2014). Calcium homeostasis
in red blood cells of dialysis patients in dependence of erythropoietin treatment.
Front. Physiol. 5:16. doi: 10.3389/fphys.2014.00016
Wang, J., Wagner-Britz, L., Bogdanova, A., Ruppenthal, S., Wiesen, K., Kaiser,
E., et al. (2013). Morphologically homogeneous red blood cells present a
heterogeneous response to hormonal stimulation. PLoS ONE 8:e67697. doi:
10.1371/journal.pone.0067697
Wesseling, M. C., Wagner-Britz, L., Boukhdoud, F., Asanidze, S., Nguyen,
D. B., Kaestner, L., et al. (2016). Measurements of intracellular Ca2+
content and phosphatidylserine exposure in human red blood cells:
methodological issues. Cell. Physiol. Biochem. 38, 2414–2425. doi: 10.1159/000
445593
Wissenschaftliche Tabellen, G. (1979). Teilband Hämatologie und Humangenetik.
Basel: CIBA-GEIGY Ltd.
World Health Organization Division of Emerging and Other Communicable
Diseases Surveillance and Control (1997). Guidelines for the Safe Transport of
Infectious Substances and Diagnostic Specimens. 15. Available online at: http://
books.google.de/books?id=FKhuHQAACAAJ&dq=intitle:Guidelines+for+
the+safe+transport+of+infectious+substances+and+diagnostic+specimens&
hl=&cd=1&source=gbs_api
Yang, L., Andrews, D. A., and Low, P. S. (2000). Lysophosphatidic acid opens a
Ca(++) channel in human erythrocytes. Blood 95, 2420–2425.
Zancan, P., and Sola-Penna, M. (2005). Calcium influx: a possible role for insulin
modulation of intracellular distribution and activity of 6-phosphofructo-
1-kinase in human erythrocytes. Mol. Genet. Metab. 86, 392–400. doi:
10.1016/j.ymgme.2005.07.005
Zylka-Menhom, V., and Siegmund-Schultze, N. (2010). Pechsteins blut - ein
expertenstreit. Deutsches Ärzteblatt 107, A538.
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
The reviewer AFM and handling Editor declared a previous collaboration
and the handling Editor states that the process nevertheless met the standards of a
fair and objective review.
Copyright © 2016 Makhro, Huisjes, Verhagen, Mañú-Pereira, Llaudet-Planas,
Petkova-Kirova, Wang, Eichler, Bogdanova, van Wijk, Vives-Corrons and Kaestner.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Physiology | www.frontiersin.org 21 July 2016 | Volume 7 | Article 288
